REQUEST A DEMO
Total
USD $0.00
Search more companies

Novartis Biosciences Peru S.A. (Peru)

Main Activities: Pharmacies and Drug Stores
Full name: Novartis Biosciences Peru S.A. Profile Updated: June 25, 2021
Buy our report for this company USD 19.99 Most recent financial data: 2019 Available in: English & Spanish Download a sample report

Novartis Biosciences Peru, started in 1962 under the name Sandoz Peru. In 1996, the name of Novartis is born from the merger of Sandoz and Ciba-Gaigy Peru.

Novartis is a pharmaceutical company that manufactures and markets diagnostic products, generic drugs, and various production for consumer health. The company has three manufacturing plants in Lima, located according to their specialization, like this: Pharmaceutical, Health Anima, Lima and Human Health.

Headquarters
Av. Juan De Arona 151, San Isidro
Lima; Lima;

Contact Details: Purchase the Novartis Biosciences Peru S.A. report to view the information.

Website: http://www.novartis.com

Basic Information
Total Employees:
Purchase the Novartis Biosciences Peru S.A. report to view the information.
Outstanding Shares:
Purchase the Novartis Biosciences Peru S.A. report to view the information.
Ratings:
Purchase the Novartis Biosciences Peru S.A. report to view the information.
Incorporation Date:
September 21, 1962
Key Executives
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Treasurer
Purchase this report to view the information.
Gerente General
Purchase this report to view the information.
Assistant
Purchase this report to view the information.
Assistant
Ownership Details
Subsidiaries
Company Performance
Financial values in the chart are available after Novartis Biosciences Peru S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PEN. Absolute financial data is included in the purchased report.
Total operating revenue
17.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?